These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31157509)

  • 21. Functional analysis of clinical
    Toh MR; Chong ST; Chan SH; Low CE; Ishak NDB; Lim JQ; Courtney E; Ngeow J
    Cold Spring Harb Mol Case Stud; 2019 Aug; 5(4):. PubMed ID: 31371347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer.
    Sabatier R; Adélaïde J; Finetti P; Ferrari A; Huiart L; Sobol H; Chaffanet M; Birnbaum D; Bertucci F
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1143-51. PubMed ID: 20842729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cooperation between a somatic mutation and a genetic susceptibility variant in Ewing sarcoma].
    Grünewald TG; Gilardi-Hebenstreit P; Charnay P; Delattre O
    Med Sci (Paris); 2016 Apr; 32(4):323-6. PubMed ID: 27137684
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.
    DuBois SG; Goldsby R; Segal M; Woo J; Copren K; Kane JP; Pullinger CR; Matthay KK; Witte J; Lessnick SL; Robison LL; Bhatia S; Strong LC
    Pediatr Blood Cancer; 2012 Jul; 59(1):52-6. PubMed ID: 21793187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically Engineered Mouse Model in Ewing Sarcoma.
    Tanaka M; Nakamura T
    Methods Mol Biol; 2021; 2226():183-189. PubMed ID: 33326102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?
    Imbert-Bouteille M; Gauthier-Villars M; Leroux D; Meunier I; Aerts I; Lumbroso-Le Rouic L; Lejeune S; Delnatte C; Abadie C; Pujol P; Houdayer C; Corsini C
    Mol Genet Genomic Med; 2019 Dec; 7(12):e913. PubMed ID: 31568710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genomic landscape of pediatric Ewing sarcoma.
    Crompton BD; Stewart C; Taylor-Weiner A; Alexe G; Kurek KC; Calicchio ML; Kiezun A; Carter SL; Shukla SA; Mehta SS; Thorner AR; de Torres C; Lavarino C; Suñol M; McKenna A; Sivachenko A; Cibulskis K; Lawrence MS; Stojanov P; Rosenberg M; Ambrogio L; Auclair D; Seepo S; Blumenstiel B; DeFelice M; Imaz-Rosshandler I; Schwarz-Cruz Y Celis A; Rivera MN; Rodriguez-Galindo C; Fleming MD; Golub TR; Getz G; Mora J; Stegmaier K
    Cancer Discov; 2014 Nov; 4(11):1326-41. PubMed ID: 25186949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.
    Huertas-Martínez J; Court F; Rello-Varona S; Herrero-Martín D; Almacellas-Rabaiget O; Sáinz-Jaspeado M; Garcia-Monclús S; Lagares-Tena L; Buj R; Hontecillas-Prieto L; Sastre A; Azorin D; Sanjuan X; López-Alemany R; Moran S; Roma J; Gallego S; Mora J; García Del Muro X; Giangrande PH; Peinado MA; Alonso J; de Alava E; Monk D; Esteller M; Tirado OM
    Cancer Lett; 2017 Feb; 386():196-207. PubMed ID: 27894957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
    Spurdle AB; Marquart L; McGuffog L; Healey S; Sinilnikova O; Wan F; Chen X; Beesley J; Singer CF; Dressler AC; Gschwantler-Kaulich D; Blum JL; Tung N; Weitzel J; Lynch H; Garber J; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Conroy D; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Selkirk CG; Daly M; Isaacs C; Stoppa-Lyonnet D; Sinilnikova OM; Buecher B; Belotti M; Mazoyer S; Barjhoux L; Verny-Pierre C; Lasset C; Dreyfus H; Pujol P; Collonge-Rame MA; ; Rookus MA; Verhoef S; Kriege M; Hoogerbrugge N; Ausems MG; van Os TA; Wijnen J; Devilee P; Meijers-Heijboer HE; Blok MJ; Heikkinen T; Nevanlinna H; Jakubowska A; Lubinski J; Huzarski T; Byrski T; Durocher F; Couch FJ; Lindor NM; Wang X; Thomassen M; Domchek S; Nathanson K; Caligo M; Jernström H; Liljegren A; Ehrencrona H; Karlsson P; ; Ganz PA; Olopade OI; Tomlinson G; Neuhausen S; Antoniou AC; Chenevix-Trench G; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1032-8. PubMed ID: 21393566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families.
    Haanpää M; Pylkäs K; Moilanen JS; Winqvist R
    BMC Med Genet; 2013 Aug; 14():82. PubMed ID: 23941127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients.
    DeLeonardis K; Sedgwick K; Voznesensky O; Matloff E; Hofstatter E; Balk S; Tung N
    Breast J; 2017 Jul; 23(4):461-464. PubMed ID: 28139868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ewing Sarcoma, an Update on Molecular Pathology with Therapeutic Implications.
    de Alava E
    Surg Pathol Clin; 2017 Sep; 10(3):575-585. PubMed ID: 28797503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
    Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
    JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer.
    Karppinen SM; Heikkinen K; Rapakko K; Winqvist R
    J Med Genet; 2004 Sep; 41(9):e114. PubMed ID: 15342711
    [No Abstract]   [Full Text] [Related]  

  • 35. RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma.
    Gharanei S; Brini AT; Vaiyapuri S; Alholle A; Dallol A; Arrigoni E; Kishida T; Hiruma T; Avigad S; Grimer R; Maher ER; Latif F
    Epigenetics; 2013 Sep; 8(9):893-8. PubMed ID: 23887284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.
    Schulz E; Valentin A; Ulz P; Beham-Schmid C; Lind K; Rupp V; Lackner H; Wölfler A; Zebisch A; Olipitz W; Geigl J; Berghold A; Speicher MR; Sill H
    J Med Genet; 2012 Jul; 49(7):422-8. PubMed ID: 22652532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
    Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
    Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential of KDM3A as a therapeutic target in Ewing Sarcoma and other cancers.
    Jedlicka P
    Expert Opin Ther Targets; 2017 Nov; 21(11):997-999. PubMed ID: 29022407
    [No Abstract]   [Full Text] [Related]  

  • 39. [Functional genomics of Ewing sarcoma].
    Grünewald TGP
    Pathologe; 2017 Nov; 38(Suppl 2):198-201. PubMed ID: 28849372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal analysis in Ewing sarcoma.
    Callen DF; Smith RD; Bourne AJ
    Pathology; 1987 Jan; 19(1):64-6. PubMed ID: 3588029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.